D
Debabrata Bandyopadhyay
Researcher at Medical College and Hospital, Kolkata
Publications - 42
Citations - 1206
Debabrata Bandyopadhyay is an academic researcher from Medical College and Hospital, Kolkata. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 35 publications receiving 1146 citations.
Papers
More filters
Journal ArticleDOI
Autologous serum therapy in chronic urticaria: a promising complement to antihistamines.
TL;DR: AST shows promise in treatment of urticaria regardless of the autoreactive nature, and patients of CU and non-AU patients showed comparable improvement of TSS.
Journal ArticleDOI
Immunotherapy in viral warts with intradermal Bacillus Calmette-Guerin vaccine versus intradermal tuberculin purified protein derivative: A double-blind, randomized controlled trial comparing effectiveness and safety in a tertiary care center in Eastern India.
Indrashis Podder,Sabari Bhattacharya,Vivek Mishra,Tushar Kanti Sarkar,Somodyuti Chandra,Amrita Sil,Santasmita Pal,Dhiraj Kumar,Abanti Saha,Koushik Shome,Debabrata Bandyopadhyay,Nilay Kanti Das +11 more
TL;DR: Bacillus Calmette–Guerin may be more effective, though it had more adverse events in the authors' study, and tuberculin purified protein derivative hold promise in the treatment of viral warts.
Journal ArticleDOI
Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study
Swosti Mohanty,Anupam Das,Anupama Ghosh,Amrita Sil,Ramesh Chandra Gharami,Debabrata Bandyopadhyay,Nilay Kanti Das +6 more
TL;DR: Cyclosporine (5 mg/kg/day) for 10 days from onset of Stevens–Johnson syndrome/toxic epidermal necrolysis may decrease the risk of dying, may provide faster healing of lesions and might lead to early discharge from hospital.
Journal ArticleDOI
Safety and effectiveness of autoinoculation therapy in cutaneous warts: A double - blind, randomized, placebo - controlled study
TL;DR: Autoinoculation may be an effective therapeutic modality for cutaneous warts and two sessions may be required for optimum results, according to the authors.